Antifibrotic Therapy for the Treatment of Pulmonary Fibrosis
- 1 October 2001
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 322 (4) , 213-221
- https://doi.org/10.1097/00000441-200110000-00012
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1999
- Interleukin-4 and interferon-γ discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsetsJournal of Cellular Physiology, 1996
- New strategies for treatment of pulmonary fibrosis.Thorax, 1995
- Dietary supplementation with taurine and niacin prevents the increase in lung collagen cross‐links in the multidose bleomycin hamster model of pulmonary fibrosisJournal of Biochemical Toxicology, 1994
- Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in miceEuropean Respiratory Journal, 1994
- New approaches to the treatment of pulmonary fibrosisEuropean Respiratory Journal, 1994
- Effects of Nicotinamide and Niacin on Bleomycin-Induced Acute Injury and Subsequent Fibrosis in Hamster LungsExperimental Lung Research, 1994
- Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.Thorax, 1989
- Effect of Murine Gamma Interferon on the Cellular Responses to Bleomycin in MiceExperimental Lung Research, 1988
- Natural History and Treated Course of Usual and Desquamative Interstitial PneumoniaNew England Journal of Medicine, 1978